Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Early Precision Diagnosis and Relapse Prediction Technology Development in High-risk Acute Leukemia and Clinical Application

NCT03297476 is registered in ClinicalTrials.gov with Zhongda Hospital as lead sponsor.

NCT NCT03297476
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03297476 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Early Precision Diagnosis and Relapse Prediction Technology Development in High-risk Acute Leukemia and Clinical Application
Lead sponsor
Zhongda Hospital
Phase
Observational
Overall status
Completed
Start date
December 1, 2017
Completion date
December 31, 2020
Enrollment
100 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

leukemia, acute